HomeEducationCOURSE CATALOGCourse Detail

What’s New in Oncology? Addressing Muscle Health and Nutrition

Program Date: 5 September 2022

Publication Date: 20 April 2023

Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0

Course Description:

In this course, faculty will review the impact of malnutrition and muscle loss on clinical outcomes in patients with cancer; summarize body composition techniques for muscle mass assessment and implications for clinical practice; and identify new clinical data on protein and hydroxymethylbutyrate (HMB) as interventions for patients with cancer. Originally presented live on September 5, 2022.

Course Objectives:

• Review the impact of malnutrition and muscle loss on clinical outcomes in patients with cancer.

• Summarize body composition techniques for muscle mass assessment and implications for clinical practice.

• Identify new clinical data on protein and hydroxymethylbutyrate (HMB) as interventions for patients with cancer.

CDR Level: 2
Performance Indicators: 8.1.2, 8.1.5, 8.2.3
Run Time: 48

Course Instructor Bio(s)

Maurizio Muscaritoli, MD

Professor, Internal Medicine

Director, Internal Medicine and Clinical Nutrition Unit

Director, Residency Training Program in Internal Medicine

Director, Master’s Degree Course in Clinical Nutrition and Metabolism

Department of Translational and Precision Medicine

Sapienza University of Rome

Rome, Italy

Dr Muscaritoli is a Professor of Internal Medicine and the Director of the Internal Medicine and Clinical Nutrition Unit at the “Policlinico Umberto I” University Hospital of the Sapienza University in Rome. Dr Muscaritoli’s research mainly focuses on clinical nutrition in chronic diseases and the study of the metabolic changes occurring in chronic diseases, with a particular focus on cancer and the mechanisms of cancer cachexia and the loss of muscle mass and function in experimental models of cancer cachexia in cancer patients. Dr Muscaritoli is the author of more than 250 national and international publications including peer-reviewed articles, papers, ESPEN clinical guidelines, including the latest ESPEN Practical Guideline: Clinical Nutrition in Cancer.

Paula Ravasco, MD, RD, MSc, PhD

Professor, Nutrition and Scientific Research of Medicine

Universidade Católica Portuguesa

Lisbon, Portugal

Dr Ravasco has a degree in Nutritional Sciences, in Nutrition and Food Engineering, as well as her Master's and PhD at the Faculty of Medicine of the University of Lisbon. She is a Professor of Clinical Nutrition and Clinical Research at the Faculty of Medicine of the University of Lisbon, a Coordination Board member of the Master’s in Clinical Nutrition, and a Principal Investigator at the Unit of Nutrition and Metabolism of the Institute of Molecular Medicine, her area of special interest is oncology.

She is the recipient of 4 research grants and 7 national or international prizes in clinical research. She has been involved in various scientific activities since May 2001. She is also an active member of several professional societies in nutrition and oncology including ESPEN where she served as an author of the 2016 ESPEN practical guideline: Clinical Nutrition in Cancer. She has been a reviewer for 17 scientific journals in nutrition/medicine/oncology since 2003.

Carla Prado, PhD, RD

Professor and Campus Alberta Innovate Program (CAIP) Chair in Nutrition, Food & Health

Director, Human Nutrition Research Unit, Division of Human Nutrition

Department of Agricultural, Food and Nutritional Science

Faculty of Agricultural, Life and Environmental Sciences

University of Alberta

Edmonton, Alberta, Canada

Dr Carla Prado is a Professor at the University of Alberta in Canada and a Campus Alberta Innovate Program (CAIP) Chair in Nutrition, Food and Health. She is also the Director of the Human Nutrition Research Unit. Dr Prado received her PhD in human nutrition and metabolism from the University of Alberta, Canada, and is a Registered Dietitian in both Canada and Brazil. Dr Prado is an expert in assessing nutritional status through the precise measurement of body composition and energy metabolism. The focus of her current research program is to develop targeted nutrition interventions for the prevention and treatment of low muscle mass in patients with diverse conditions. She is currently the principal investigator for four randomized controlled trials investigating the impact of nutrition intervention on body composition and health. She is currently a member of the GLIM Body Composition Working Group, and the Sarcopenic Obesity Consensus Group (ESPEN/EASO). She is an Associate Editor of Clinical Nutrition and the Journal of Cachexia, Sarcopenia and Muscle.

Abbott Nutrition’s Provider Statement for Nursing CEs:

Abbott Nutrition Health Institute is an approved provider of continuing nursing education by the California Board of Registered Nursing Provider #CEP 11213.

Abbott Nutrition’s Provider Statement for Dietitian CPEUs:

Abbott Nutrition Health Institute (RO002), is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR credentialed practitioners will receive continuing professional education units (CPEUs) for completion of this program/materials. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

In addition to completing an online evaluation, participants of our programs can provide feedback directly to CDR.